Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 24% ± 4% | |
macrophage | 4 studies | 38% ± 29% | |
conventional dendritic cell | 3 studies | 45% ± 36% | |
non-classical monocyte | 3 studies | 20% ± 2% | |
basal cell | 3 studies | 42% ± 34% | |
dendritic cell | 3 studies | 46% ± 32% |
Insufficient scRNA-seq data for expression of COQ2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 452.98 | 653 / 653 | 100% | 14.12 | 603 / 605 |
uterus | 100% | 494.68 | 170 / 170 | 100% | 19.88 | 457 / 459 |
breast | 100% | 368.92 | 458 / 459 | 100% | 14.45 | 1115 / 1118 |
intestine | 100% | 466.92 | 963 / 966 | 100% | 19.63 | 526 / 527 |
ovary | 100% | 534.66 | 180 / 180 | 99% | 12.41 | 427 / 430 |
esophagus | 99% | 427.30 | 1434 / 1445 | 100% | 13.71 | 183 / 183 |
stomach | 99% | 292.97 | 356 / 359 | 100% | 16.69 | 286 / 286 |
skin | 100% | 898.29 | 1809 / 1809 | 99% | 12.82 | 468 / 472 |
prostate | 100% | 422.03 | 244 / 245 | 99% | 15.67 | 499 / 502 |
lung | 99% | 470.23 | 572 / 578 | 100% | 16.30 | 1154 / 1155 |
bladder | 100% | 322.62 | 21 / 21 | 98% | 16.15 | 494 / 504 |
adrenal gland | 100% | 1372.95 | 258 / 258 | 98% | 14.45 | 225 / 230 |
pancreas | 98% | 221.71 | 320 / 328 | 99% | 11.24 | 177 / 178 |
liver | 100% | 444.21 | 225 / 226 | 97% | 8.68 | 395 / 406 |
kidney | 100% | 409.78 | 89 / 89 | 96% | 9.08 | 867 / 901 |
brain | 89% | 191.69 | 2351 / 2642 | 100% | 11.62 | 703 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 12.75 | 29 / 29 |
muscle | 100% | 877.46 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 724.52 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 22.81 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.51 | 1 / 1 |
adipose | 100% | 405.04 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 283.43 | 1305 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 673.80 | 836 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 497.48 | 875 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 9.12 | 73 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006071 | Biological process | glycerol metabolic process |
GO_0008299 | Biological process | isoprenoid biosynthetic process |
GO_0006744 | Biological process | ubiquinone biosynthetic process |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0047293 | Molecular function | 4-hydroxybenzoate nonaprenyltransferase activity |
GO_0004659 | Molecular function | prenyltransferase activity |
GO_0008412 | Molecular function | 4-hydroxybenzoate octaprenyltransferase activity |
GO_0002083 | Molecular function | 4-hydroxybenzoate decaprenyltransferase activity |
Gene name | COQ2 |
Protein name | 4-hydroxybenzoate polyprenyltransferase, mitochondrial (4-HB polyprenyltransferase) (EC 2.5.1.39) (4-hydroxybenzoate decaprenyltransferase) (Para-hydroxybenzoate--polyprenyltransferase) (PHB:PPT) (PHB:polyprenyltransferase) Coenzyme Q2, polyprenyltransferase 4-hydroxybenzoate polyprenyltransferase, mitochondrial (4-HB polyprenyltransferase) (EC 2.5.1.39) (4-hydroxybenzoate decaprenyltransferase) (COQ2 homolog) (hCOQ2) (Para-hydroxybenzoate--polyprenyltransferase) (PHB:PPT) (PHB:polyprenyltransferase) |
Synonyms | CL640 |
Description | FUNCTION: Mediates the second step in the final reaction sequence of coenzyme Q (CoQ) biosynthesis . Catalyzes the prenylation of para-hydroxybenzoate (PHB) with an all-trans polyprenyl donor (such as all-trans-decaprenyl diphosphate) . The length of the polyprenyl side chain varies depending on the species, in humans, the side chain is comprised of 10 isoprenyls (decaprenyl) producing CoQ10 (also known as ubiquinone), whereas rodents predominantly generate CoQ9 . However, this specificity is not complete, human tissues have low amounts of CoQ9 and rodent organs contain some CoQ10 . Plays a central role in the biosynthesis of CoQ10 . CoQ10 is a vital molecule that transports electrons from mitochondrial respiratory chain complexes . CoQs also function as cofactors for uncoupling protein and play a role as regulators of the extracellularly-induced ceramide-dependent apoptotic pathway . Regulates mitochondrial permeability transition pore (mPTP) opening and ROS production (pivotal events in cell death) in a tissue specific manner (By similarity). . FUNCTION: Mediates the second step in the final reaction sequence of coenzyme Q (CoQ) biosynthesis. Catalyzes the prenylation of para-hydroxybenzoate (PHB) with an all-trans polyprenyl donor (such as all-trans-decaprenyl diphosphate or trans-nonaprenyl diphosphate). The length of the polyprenyl side chain varies depending on the species, in humans, the side chain is comprised of 10 isoprenyls producing CoQ10 (also known as ubiquinone), whereas rodents predominantly generate CoQ9. However, this specificity is not complete, human tissues have low amounts of CoQ9 and rodent organs contain some CoQ10. CoQs are vital molecules that transport electrons from mitochondrial respiratory chain complexes. CoQs also function as cofactors for uncoupling protein and play a role as regulators of the extracellularly-induced ceramide-dependent apoptotic pathway. Regulates mitochondrial permeability transition pore (mPTP) opening and ROS production (pivotal events in cell death) in a tissue specific manner. . |
Accessions | ENST00000311469.9 [Q96H96-4] ENST00000311461.7 ENST00000311461.7 [Q96H96-3] E2QRG7 ENST00000503391.5 ENST00000503915.5 ENST00000647002.2 [Q96H96-1] H0YAI0 E7EPM7 Q96H96 |